Fusion Curation Interface: An Educational Tool to Explore a Unified Framework
Explore a unified framework for representing and curating gene fusions using an educational tool designed for cancer genomics professionals.
Association Between Clonal Hematopoiesis and Inherited Cancer Susceptibility Genes
Explore the link between clonal hematopoiesis and inherited cancer susceptibility genes in this concise presentation from the 2022 CGC Annual Meeting.
Genetic Spectrum of RAS Alterations - A Highlight of In-Frame Insertion Variants in Association with Vascular Anomalies
Explore genetic spectrum of RAS alterations, focusing on in-frame insertion variants associated with vascular anomalies. Gain insights into clinical cancer genomics and best practices.
Current Trends in Cancer Immunotherapy with a Focus on Cytokine Therapies
Explore cytokine therapies in cancer immunotherapy, including their role in tumor microenvironments, clinical trials, receptor blockade, and future directions. Gain insights into Sino Biological's research support.
Early ctDNA Molecular Response Enhanced Through Integrated Analyses of Cell-Free DNA and Matched White Blood Cells
Explore advancements in liquid biopsies for early cancer detection and monitoring through integrated analyses of cell-free DNA and matched white blood cells.
The Evolution of Precision Diagnostics in Advancing Treatment Strategies of Solid Tumors
Explore advancements in multi-omic approaches for comprehensive tumor analysis, accelerating precision medicine development while addressing challenges in diagnostic laboratory integration.
The Future of Antibody Drug Discovery - From Target Validation to Candidate Selection
Explore the antibody drug discovery process, from target validation to candidate selection, highlighting key steps, advancements, and challenges in developing effective therapeutics.
Immunophenotyping Unleashed - A Partner in Panel Design
Explore multicolor flow cytometry advancements, panel design strategies, and optimization techniques for complex immunophenotyping experiments in this comprehensive webinar.
Insights into Cancer Genomics via COSMIC v98
Explore cancer genomics through COSMIC v98, learning about new cancer genes, download files, IDs, and data improvements in this comprehensive overview.
From 50 to 500 Genes: How to Scale to Comprehensive Genomic Profiling While Reducing Cost, Time and Labor
Discover a workflow-agnostic software solution for scaling to comprehensive genomic profiling, reducing costs and time while leveraging a vast knowledge base for accelerated variant interpretation and patient-specific reporting.
Enumeration and Molecular Profiling of Circulating Tumor Cells for Diagnosis and Therapeutic Monitoring of Metastatic Cancer
Explore liquid biopsy techniques for non-invasive tumor analysis. Learn about circulating tumor cell enumeration and molecular profiling for cancer diagnosis and monitoring.
HRD Evaluation and Scoring Using OncoScan CNV Assay - A Whole-Genome Microarray Research Solution
Explore HRD evaluation and scoring using OncoScan CNV Assay, a whole-genome microarray research solution for detecting genome-wide biomarkers in ovarian and breast cancers.
Post-gel Era for Paraproteinemia Analysis
Explore advanced methods for detecting monoclonal proteins, including mass spectrometry-based analysis. Learn to address challenges in paraproteinemia diagnosis and understand therapeutic antibody interference.
Development of a Novel Targeted NGS Panel for Analysis of DNA Methylation Biomarkers in Lung Cancer
Explore DNA methylation biomarkers in lung cancer through a novel targeted NGS panel, overcoming technical limitations for potential clinical applications in diagnosis and treatment.
HRD Evaluation and Scoring Using OncoScan CNV Assay - A Whole-Genome Microarray Research Solution
Explore HRD evaluation and scoring using OncoScan CNV Assay, a whole-genome microarray solution for cancer research, focusing on PARP inhibitors and synthetic lethality in tumors.
How to Translate Complex Genomic Data to Clinically-Oriented Personalized Cancer Care
Explore real-world application of translating complex genomic data into personalized cancer care, focusing on NGS testing and variant interpretation for hereditary cancers.
Moving Beyond Mutation - AI-driven Functional Precision Medicine for Cancer
Explore AI-driven functional precision medicine for cancer, combining live-cell assays, immune profiling, and machine learning to predict drug efficacy and improve treatment outcomes.
Precision Medicine as a Population Health Strategy
Explore precision medicine's impact on population health, from genomics in oncology to pharmacogenomics. Learn about broad sequencing panels and their potential to alter disease trajectories across populations.
Advancing Cancer Research with Tools for Liquid Biopsy
Explore cutting-edge tools for liquid biopsy in cancer research, enhancing early detection and treatment effectiveness. Learn from expert Dr. Laure Jobert about innovative approaches to combat this global health challenge.
Current Status of Detecting Monoclonal Antibodies and Free Light Chains in Serum
Explore advancements in detecting monoclonal antibodies and free light chains in serum for diagnosing and monitoring multiple myeloma and related disorders. Learn about new testing methods and their clinical implications.
Reprogramming Natural Killer Cells for Cancer Immunotherapy
Explore genetic engineering approaches to enhance natural killer cells for cancer immunotherapy, focusing on overcoming challenges in targeting aggressive solid tumors and improving immune responses.